3851 - 3860 of 8808 Results
Title
Year
-
OPENTitle: Falls Risk in Relation to Activity Exposure in High-Risk Older AdultsJournal Name: The Journals of Gerontology: Series APublisher: Oxford University Press (OUP)Vol: 75Issue #: 6Start Page: 1198End Page: 1205Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1093/gerona/glaa007Best OA location URL: https://academic.oup.com/biomedgerontology/article-pdf/75/6/1198/33283332/glaa007.pdfCitation Count: 66
-
OPENTitle: Mitomycin-C treatment during differentiation of induced pluripotent stem cell-derived dopamine neurons reduces proliferation without compromising survival or function in vivoJournal Name: Stem Cells Translational MedicinePublisher: Oxford University Press (OUP)Vol: 10Issue #: 2Start Page: 278End Page: 290Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/sctm.20-0014Best OA location URL: https://stemcellsjournals.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/sctm.20-0014Citation Count: 21
-
RESTRICTEDTitle: Cell Replacement Therapy in Parkinson’s Disease—History of Development and Prospects for Use in Clinical PracticeJournal Name: Molecular BiologyPublisher: Pleiades Publishing LtdVol: 54Issue #: 6Start Page: 827End Page: 839Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1134/s0026893320060060Citation Count: 2
-
OPENTitle: PINK1-dependent phosphorylation of Serine111 within the SF3 motif of Rab GTPases impairs effector interactions and LRRK2-mediated phosphorylation at Threonine72Journal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 477Issue #: 9Start Page: 1651End Page: 1668Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20190664Best OA location URL: https://portlandpress.com/biochemj/article-pdf/477/9/1651/878955/bcj-2019-0664.pdfCitation Count: 39
-
RESTRICTEDTitle: Patient-centred management of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 888End Page: 889Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30355-0Citation Count: 0
-
OPENTitle: Huntington's disease in BangladeshJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 8Start Page: 644End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30216-7Best OA location URL: http://www.thelancet.com/article/S1474442220302167/pdfCitation Count: 1
-
OPENTitle: Long before Huntington's disease: what matters most?Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 473End Page: 475Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s1474-4422(20)30156-3Best OA location URL: http://www.thelancet.com/article/S1474442220301563/pdfCitation Count: 0
-
RESTRICTEDTitle: Developing therapies for Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 10Start Page: 797End Page: 797Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3Best OA location URL: http://www.thelancet.com/article/S1474442220303203/pdfCitation Count: 5
-
RESTRICTEDTitle: Multiple sclerosis in 2019: predicting progressionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 12End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30441-7Citation Count: 1
-
OPENTitle: A cornerstone initiative for progress in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30432-6Best OA location URL: http://www.thelancet.com/article/S1474442219304326/pdfCitation Count: 1